Activation of natural killer cells by newcastle disease virus hemagglutinin-neuraminidase
/in International Publications, IOZK Veröffentlichungen, Newcastle Disease Virus /von 2009-06-10 / J. Virol. 2009 Aug;83(16):8108-21Cutting Edge: TLR-Dependent viral recognition along with type I IFN positive feedback signaling masks the requirement of viral replication for IFN-{alpha} production in plasmacytoid dendritic cells
/in International Publications, Newcastle Disease Virus /von 2009-04-01 / J. Immunol. 2009 Apr;182(7):3960-4Expression of RIG-I, IRF3, IFN-beta and IRF7 determines resistance or susceptibility of cells to infection by Newcastle Disease Virus
/in International Publications, IOZK Veröffentlichungen, Newcastle Disease Virus /von 2009-04-01 / Int. J. Oncol. 2009 Apr;34(4):971-82Cross-infection of tumor cells by contact with T lymphocytes loaded with Newcastle disease virus
/in International Publications, IOZK Veröffentlichungen, Newcastle Disease Virus /von 2009-04-01 / Int. J. Oncol. 2009 Apr;34(4):951-62Genetically engineered Newcastle disease virus for malignant melanoma therapy
/in International Publications, Malignant Melanoma, Newcastle Disease Virus /von 2009-02-26 / Gene Ther. 2009 Jun;16(6):796-804Enhancement of oncolytic properties of recombinant newcastle disease virus through antagonism of cellular innate immune responses
/in International Publications, Newcastle Disease Virus /von 2009-02-10 / Mol. Ther. 2009 Apr;17(4):697-706Antitumoral immune response by recruitment and expansion of dendritic cells in tumors infected with telomerase-dependent oncolytic viruses
/in Dendritic Cells, International Publications, Newcastle Disease Virus /von 2009-02-03 / Cancer Res. 2009 Feb;69(4):1448-58The extrinsic RNA-sensing pathway for adjuvant immunotherapy of cancer
/in International Publications, Newcastle Disease Virus /von 2009-01-31 / Cancer Immunol. Immunother. 2009 Aug;58(8):1175-84Newcastle disease virus represses the activation of human hepatic stellate cells and reverses the development of hepatic fibrosis in mice
/in International Publications, Newcastle Disease Virus /von 2009-01-28 / Liver Int. 2009 Apr;29(4):593-602IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de